Skip to main content
. 2018 Feb 23;19(2):176–183. doi: 10.1002/acm2.12284

Table 2.

Comparison of preclinical VMAT SRS plan with treated iPlan plans for five cases (4–6 lesions per patient)

Preclinical plans
iPlan VMAT
GI 3.7 ± 0.6 4.2 ± 0.9
CI 1.4 ± 0.2 1.2 ± 0.1
Brain D mean (Gy) 2.3 ± 0.5 2.6 ± 0.2
Brain V2 Gy (%) 37 ± 6 47 ± 2
Brain V 7 Gy (%) 6 ± 3 4 ± 2